Moffitt Cancer Center has announced a new group of Section Heads across its Gastrointestinal Oncology Program, highlighting continued investment in disease-focused leadership, multidisciplinary collaboration, and innovation in cancer care.

The appointments bring together experts across colorectal, neuroendocrine, pancreatic, hepatobiliary, gastric, esophageal, and peritoneal malignancies, reinforcing Moffitt’s role as a leading center for gastrointestinal cancer research and treatment.

GI Medical Oncology Section Heads

Images	Name
	Tiago Biachi – Section Head for Colorectal Cancer Dr. Tiago Biachi de Castria is an Associate Member in the Department of Gastrointestinal Oncology at Moffitt Cancer Center. His clinical and research interests focus on colorectal and hepatobiliary cancers, particularly biomarkers and drug development. Originally trained in Brazil, he completed advanced gastrointestinal oncology fellowship training at Memorial Sloan Kettering Cancer Center. Dr. Biachi has also served in academic leadership roles at the University of São Paulo and has extensive experience in gastrointestinal oncology clinical research.
	Jonathan Strosberg – Section Head for Neuroendocrine Tumors Dr. Jonathan Strosberg is a Professor at Moffitt Cancer Center and internationally recognized expert in neuroendocrine malignancies. He leads Moffitt’s Neuroendocrine Tumor Division and Department of Gastrointestinal Oncology Research Program. A graduate of Harvard University and Cornell University Medical College, Dr. Strosberg has authored more than 150 publications, including studies in the National Cancer Institute portfolio and major oncology journals. He also serves on leadership committees for NANETS and NCCN.
	Dae Won Kim – Section Head for Pancreatic Cancer Dr. Dae Won Kim specializes in gastrointestinal malignancies with a strong focus on immunotherapy approaches. He earned his medical degree from Inha University School of Medicine in South Korea and completed fellowship training at both MD Anderson Cancer Center and Moffitt Cancer Center. His clinical interests include pancreatic and other gastrointestinal cancers, particularly the development of innovative immunotherapeutic strategies. Dr. Kim’s appointment reflects Moffitt’s growing emphasis on translational and immune-based GI cancer research.
	Iman Imanirad – Section Head for Peritoneal Malignancies Dr. Iman Imanirad is an Assistant Member at Moffitt Cancer Center and Professor of Oncology at the University of South Florida College of Medicine. His clinical and research work centers on colorectal, appendiceal, and peritoneal cancers. Dr. Imanirad has led clinical research efforts including investigator-initiated studies in gastrointestinal malignancies and has published extensively in peer-reviewed oncology journals. He has also been recognized with multiple institutional awards for clinical and academic excellence.
	Allan Lima Pereira – Section Head for Esophageal and Gastric Cancers Dr. Allan Lima Pereira is an Associate Member in the Department of Gastrointestinal Oncology at Moffitt Cancer Center. Originally from Brazil, he completed oncology training and later pursued fellowship training at MD Anderson Cancer Center. His clinical and research interests span gastrointestinal cancers, with a particular focus on colorectal and hepatopancreatobiliary tumors, biomarkers, and clinical trial development. Dr. Pereira has held academic positions at leading Brazilian cancer institutions and continues to contribute to translational GI oncology research.
	Richard Kim – Section Head for Liver Cancer Dr. Richard Kim serves as Service Chief of Medical Gastrointestinal Oncology and Senior Member at Moffitt Cancer Center. He is also a Professor of Oncology at the University of South Florida College of Medicine. His work focuses heavily on hepatobiliary and gastrointestinal malignancies, including immunotherapy and targeted therapy development. Dr. Kim has led numerous phase I, II, and III clinical trials and has published in major journals including JAMA Oncology, Lancet Oncology, and the Journal of Clinical Oncology. He is widely recognized for his contributions to gastrointestinal oncology education and clinical research leadership.